How to Choose Blood Collection Tubes: A U.S. Healthcare Purchasing Guide

Summary

• Choose blood collection tubes based on the intended laboratory tests, specimen requirements, additive, tube size, fill volume, and compatibility with the collection system.
• Evaluate U.S. suppliers for regulatory status, quality systems, lot traceability, expiration dates, storage conditions, supply continuity, and customer support—not price alone.
• Use documented purchasing controls, validation procedures, staff training, and inventory management to reduce rejected specimens, inaccurate results, waste, and compliance risk.

Blood collection tubes are among the most frequently used products in clinical laboratories, hospitals, physician offices, outpatient centers, blood donation facilities, and Mobile Phlebotomy services. Although a tube may appear to be a simple disposable container, its material, additive, vacuum level, dimensions, closure, sterility, and manufacturing quality can directly affect Specimen Integrity and laboratory results.

In the United States, purchasing blood collection tubes requires more than comparing catalog prices. Buyers must consider test compatibility, regulatory requirements, collection procedures, transportation conditions, storage capacity, supply continuity, and the supplier’s ability to provide consistent product quality. A low-cost tube that causes hemolysis, insufficient volume, clotting, contamination, or Specimen Rejection may be considerably more expensive than a higher-priced product that performs reliably.

The scale of blood collection makes these decisions especially important. The Centers for Disease Control and Prevention has reported that billions of laboratory tests are performed in the United States each year. Although the exact annual number varies by definition and data source, laboratory testing is widely recognized as supporting the majority of clinical decisions. Since many of those tests begin with venous or Capillary Blood Collection, even a small error rate can affect a substantial number of patients.

This article explains the principal factors U.S. healthcare organizations should evaluate when purchasing blood collection tubes from domestic suppliers, distributors, and manufacturers.

1. Match the Tube to the Intended Laboratory Test

The first purchasing question should be: Which tests will be performed using these tubes? Different laboratory departments require different tube types, and tubes that look similar may contain completely different additives. The wrong tube can produce an unusable specimen or an inaccurate result.

Common tube categories include serum tubes, plasma tubes, whole-blood tubes, coagulation tubes, trace-element tubes, Blood Culture bottles or tubes, and specialized molecular or stabilizing systems. Color coding is helpful, but it is not sufficient by itself. Tube colors may differ among manufacturers, facilities, and product lines. Buyers should confirm the additive and intended use printed on the label and described in the manufacturer’s instructions.

Serum tubes

Serum tubes are commonly used for chemistry, immunology, serology, endocrinology, and some Therapeutic Drug Monitoring procedures. A plain serum tube contains no Anticoagulant and allows blood to clot before centrifugation. Serum separator tubes contain a Clot Activator and a polymer gel designed to separate serum from cells after centrifugation.

When evaluating serum tubes, purchasing teams should determine whether the laboratory’s analyzers and testing methods have been validated with the proposed tube. Clot Activator performance, Clotting Time, gel position, gel stability, and compatibility with centrifuges can vary. Some tests may be affected by gel contact, specimen transfer, or prolonged storage.

Plasma and whole-blood tubes

Plasma tubes contain anticoagulants such as lithium Heparin, sodium Heparin, or EDTA. They are used for many chemistry, hematology, and specialized applications. EDTA tubes are frequently used for complete blood counts because EDTA preserves cellular characteristics better than many other anticoagulants. However, EDTA is unsuitable for certain chemistry tests because it binds calcium and may introduce potassium or other ions.

Whole-blood tubes may also contain EDTA or other additives. They are often used for hematology, glycated hemoglobin testing, blood typing, and selected molecular or genetic procedures. Before purchasing, confirm whether the laboratory requires lavender, pink, royal blue, tan, gray, or another tube configuration and whether the additive concentration is appropriate for the method.

Coagulation tubes

Coagulation testing generally requires Sodium Citrate tubes, commonly identified by a light-blue closure. The blood-to-additive ratio is critical. A standard citrate tube is generally designed for a ratio of nine parts blood to one part citrate, although the laboratory must follow the specific product and test instructions.

Underfilling can create excess citrate relative to plasma and may produce misleading coagulation results. Overfilling can also affect the ratio. Buyers should therefore examine the tube’s nominal draw volume, vacuum performance, acceptable fill range, and compatibility with the facility’s Phlebotomy Equipment. Facilities that collect from patients with difficult venous access may need a documented policy for low-volume or pediatric coagulation specimens.

2. Examine Additives and Their Concentrations

The additive is one of the most important technical characteristics of a blood collection tube. It determines how the specimen behaves after collection and whether it is suitable for a specific test. Buyers should request complete product specifications rather than relying only on closure color or a short catalog description.

Important additive categories include:

1. EDTA, commonly used to prevent clotting in hematology and selected molecular applications.
2. Sodium Citrate, commonly used for coagulation testing and certain specialized procedures.
3. Lithium Heparin or sodium Heparin, commonly used for plasma chemistry and selected blood gas or special testing applications.
4. Clot activators, which accelerate clot formation in serum collection.
5. Separator gels, which create a physical barrier between serum or plasma and blood cells following centrifugation.
6. Sodium Fluoride and other glycolysis inhibitors, which may be used for specific glucose-related applications.
7. Special trace-element or metal-free formulations, which are designed to minimize contamination during elemental analysis.

Additive concentrations may differ between tube sizes. A manufacturer may offer the same closure color in pediatric, adult, and microcollection formats, but the amount of additive must be proportionate to the intended specimen volume. Purchasing teams should verify that each size is designed for the required blood volume and that the laboratory has approved the configuration.

It is also important to review additive carryover risk. For example, contamination from an EDTA tube can affect calcium, magnesium, and potassium measurements, while contamination from a citrate tube can affect coagulation or chemistry testing. The order of draw established by the facility should be consistent with current laboratory procedures and the tube manufacturer’s instructions.

3. Confirm Tube Size, Draw Volume, and Vacuum Performance

Blood collection tubes are available in a wide range of sizes, including standard adult tubes, short-draw tubes, pediatric tubes, and Microcollection Tubes. The appropriate size depends on the patient population, test requirements, analyzer volume, and collection method.

Purchasers should compare the following specifications:

1. Tube length and outside diameter.
2. Nominal draw volume.
3. Minimum acceptable fill volume.
4. Dead volume remaining after processing.
5. Vacuum strength and expected draw performance.
6. Compatibility with the facility’s holders, adapters, needles, and automated systems.
7. Whether the tube can be centrifuged using existing equipment.

Vacuum performance is particularly important. A tube that draws too little blood may produce an incorrect additive-to-blood ratio. A tube that draws too much may be difficult to use safely or may exceed the required specimen volume for a child or frail patient. Over time, vacuum can change because of aging, seal defects, temperature exposure, or packaging damage.

U.S. healthcare organizations should evaluate products using representative lots rather than assuming that all tubes perform identically. A receiving inspection may include checking the tube label, dimensions, fill volume, vacuum behavior, stopper integrity, and expiration date. Facilities should document acceptance criteria before approving a new product.

4. Review Regulatory and Quality Requirements

Blood collection tubes used in U.S. healthcare settings are generally regulated as medical devices. The exact regulatory pathway and classification can vary according to the product’s design and intended use. Buyers should ask the supplier for appropriate regulatory documentation, including the product’s status with the U.S. Food and Drug Administration, applicable establishment information, and labeling that describes the intended use.

Regulatory status alone does not guarantee that a tube is appropriate for every test or laboratory. The purchasing organization remains responsible for confirming that the tube is suitable for its procedures and that changes are controlled.

Suppliers should also be evaluated for their quality management systems. Relevant evidence may include:

1. Quality certification, such as an applicable ISO 13485 medical-device quality management certification.
2. Documented manufacturing controls and inspection procedures.
3. Lot release and batch testing records.
4. Corrective and preventive action processes.
5. Complaint handling and adverse-event reporting procedures.
6. Change-notification policies for materials, additives, packaging, manufacturing sites, or specifications.
7. Traceability from the customer shipment back to the manufacturing lot and raw materials where applicable.

Laboratories operating under the Clinical Laboratory Improvement Amendments, or CLIA, must maintain procedures that support accurate, reliable testing. Accreditation organizations such as the College of American Pathologists and The Joint Commission may also examine specimen collection, identification, handling, and Quality Control processes. Tube purchasing should therefore be integrated into the laboratory’s broader quality system rather than treated as an ordinary office-supply purchase.

5. Consider CLSI Guidance and Laboratory Validation

The Clinical and Laboratory Standards Institute publishes widely used consensus guidance for blood collection, order of draw, venous and capillary collection, specimen handling, and quality practices. While organizations should follow the current edition of applicable guidance and their own laboratory procedures, CLSI recommendations provide a useful framework for evaluating tube performance.

When introducing a new tube or changing suppliers, the laboratory may need to perform a verification or validation study. The scope depends on the tube’s intended use and the potential effect on Test Results. A practical evaluation can include:

1. Comparing results from the current and proposed tubes using patient specimens or suitable control materials.
2. Checking specimen appearance, clot formation, hemolysis, lipemia, and fibrin.
3. Evaluating centrifugation time, gel barrier formation, and specimen transfer.
4. Assessing compatibility with analyzers, aliquoting systems, and pneumatic tube transport.
5. Reviewing rejection rates before and after implementation.
6. Documenting acceptance criteria, exceptions, and approval by laboratory leadership.

Validation is particularly important for coagulation, Therapeutic Drug Monitoring, blood bank testing, molecular testing, trace-element analysis, and tests known to be sensitive to specimen matrix or container materials. The manufacturer should provide technical support during the evaluation and should identify any analyte limitations.

6. Evaluate Material, Stopper, and Tube Construction

Most blood collection tubes are manufactured from glass or plastic, commonly polyethylene terephthalate. Each material has advantages and limitations. Plastic tubes are generally lighter and less likely to break, while glass may have different barrier and surface characteristics. The decision should consider patient safety, transportation, centrifugation, analyzer handling, and the laboratory’s validated methods.

The stopper is also important. It must maintain the vacuum, resist leakage, support safe needle penetration, and limit evaporation or contamination. Some tubes use a rubber stopper with a protective shield, while others use specialized closure systems. Buyers should review compatibility with tube holders and blood collection sets, including whether the stopper can be punctured consistently without excessive force.

Manufacturing defects can include cracks, incomplete seals, particulate contamination, incorrect labels, missing additives, gel abnormalities, or inconsistent vacuum. Procurement contracts should define how such defects are reported, investigated, replaced, and documented.

For facilities that use automated laboratory systems, dimensions and bar-code placement deserve special attention. A tube may be clinically suitable but operationally unsuitable if a track system cannot read its label, if the tube is unstable in a rack, or if an analyzer cannot recognize its height or diameter.

7. Prioritize Sterility, Cleanliness, and Contamination Control

Not every blood collection tube is sterile in the same way or intended for the same level of contamination control. Buyers should distinguish between products labeled sterile, products manufactured under controlled conditions, and products intended only for routine diagnostic collection. The appropriate requirement depends on the intended testing and the facility’s risk assessment.

For blood cultures and other applications where contamination can lead to false-positive results, collection materials must be selected and handled carefully. Blood Culture systems are specialized products and should not be substituted with ordinary serum or plasma tubes. The supplier should provide clear instructions about storage, preparation, collection volume, and transport.

Trace-element and Toxicology testing may require tubes with specially controlled materials. Standard tubes can contain trace amounts of metals or other substances that interfere with highly sensitive assays. If the laboratory performs lead, mercury, arsenic, aluminum, or other elemental testing, it should obtain a written suitability statement and review contamination limits.

8. Check Shelf Life, Storage, and Shipping Conditions

Blood collection tubes have expiration dates because vacuum, additive performance, stopper integrity, and gel behavior can change over time. A supplier that offers a low price but ships short-dated inventory may create avoidable waste and operational risk.

Purchasing agreements should specify a minimum remaining shelf life at delivery. The required period may differ by organization, but many facilities seek enough remaining life to support normal consumption, emergency stock, and product rotation. The receiving department should record lot numbers and expiration dates and should use a first-expire, first-out inventory method.

Storage conditions must follow the manufacturer’s instructions. Excessive heat, freezing, humidity, sunlight, and repeated temperature fluctuations may affect tube performance. During the summer, suppliers should explain how products are protected during domestic transportation. A shipment that arrives in an unconditioned trailer or remains for hours in direct sunlight may need to be quarantined until its condition is assessed.

Packaging should protect tubes from impact and moisture. Damaged cartons, crushed tubes, leaking containers, broken glass, or compromised seals should be documented immediately. The procurement contract should establish whether the supplier pays for replacement, freight, investigation, and disposal.

9. Assess Supplier Reliability and Supply Continuity

The United States has experienced recurring disruptions involving medical devices, laboratory consumables, transportation, raw materials, and manufacturing capacity. The Covid-19 pandemic demonstrated how quickly demand can exceed available supply. Blood collection tubes were among the products affected by increased testing and constrained global manufacturing capacity.

Supplier evaluation should therefore include business continuity, not just current availability. Ask whether the supplier has multiple manufacturing sites, alternate raw-material sources, safety stock, regional distribution centers, and a formal shortage communication process. It is also useful to understand whether the supplier is a manufacturer, an authorized distributor, or a broker purchasing from changing sources.

Important questions include:

1. What is the normal lead time and how much can it change during a shortage?
2. Does the supplier allocate products among customers during constrained supply?
3. How much inventory is held in U.S. distribution centers?
4. Can the supplier provide advance notice of discontinuations or product changes?
5. Is there an approved substitute with equivalent additive, volume, and performance characteristics?
6. Can the supplier provide lot-level traceability during a recall?

Large hospitals and integrated delivery networks may benefit from dual sourcing. However, adding a second tube brand can create validation, training, storage, and labeling complexity. A backup product should be evaluated before an emergency occurs, not after the primary product becomes unavailable.

10. Compare Total Cost of Ownership

Unit price is only one part of the financial calculation. A more useful approach is to estimate the total cost of ownership. This includes the purchase price, freight, storage, staff time, wastage, Specimen Rejection, redraws, regulatory documentation, and costs associated with changing products.

For example, a tube that costs a few cents less but increases Specimen Rejection by even a small percentage may generate additional costs. A rejected specimen can require a nurse or phlebotomist to recollect blood, a courier to make another trip, laboratory staff to repeat processing, and a patient to spend additional time at the facility. In hospitals, redraws may also delay treatment or discharge.

Buyers should request transparent pricing that identifies:

1. Price per tube and price per case.
2. Case quantity and minimum order requirements.
3. Freight, fuel surcharges, and hazardous-material fees where applicable.
4. Volume discounts and contract pricing.
5. Price-protection periods.
6. Return, replacement, and credit policies.
7. Costs for special labeling, bar coding, or customized packaging.

Healthcare organizations can use historical data to estimate the financial effect of product selection. Useful measures include tubes used per patient, tubes discarded because of expiration, redraw rates, Specimen Rejection rates, hemolysis rates, and emergency shipping expenses. The best supplier is often the one that lowers total operational cost while maintaining quality, rather than the one with the lowest catalog price.

11. Review Packaging, Sustainability, and Waste

Large healthcare organizations are increasingly examining the environmental impact of disposable medical products. Blood collection tubes cannot be reused, and many are disposed of as regulated medical waste after use. Nevertheless, purchasing decisions can reduce unnecessary waste through appropriate sizing, efficient packaging, and responsible inventory control.

Buyers may ask whether the supplier uses recyclable secondary packaging, minimizes excess cardboard and plastic, and provides case quantities that match actual consumption. Facilities should avoid ordering more tubes than can be used before expiration. Smaller or Microcollection Tubes may reduce blood volume drawn from pediatric and Geriatric Patients, but they should be used only when approved for the intended tests.

Environmental claims should be specific and documented. Terms such as “eco-friendly” are not enough. Procurement teams should ask for information about packaging materials, recycled content, disposal instructions, and any applicable environmental certifications. Sustainability should support, not replace, clinical and regulatory requirements.

12. Verify Labeling, Bar Codes, and Documentation

Accurate patient identification is a central safety requirement in phlebotomy. Tubes should provide adequate space for patient labels, readable lot information, expiration dates, and other required identifiers. Bar codes must be compatible with the facility’s Laboratory Information System and scanning equipment.

Before ordering, confirm whether the supplier follows the facility’s preferred bar-code standards and whether the printed information remains readable after refrigeration, centrifugation, condensation, and handling. If tubes are supplied in trays or racks, determine whether the packaging includes a scannable case or lot identifier for inventory control.

Each product should be accompanied by current instructions for use, safety information, storage requirements, and technical specifications. The supplier should notify customers when these documents change. Documentation should be retained according to the organization’s purchasing and quality policies.

13. Consider Staff Usability and Patient Safety

A tube can meet its technical specifications and still be difficult to use. Phlebotomists should evaluate stopper puncture force, tube stability, label placement, ease of insertion into holders, draw consistency, and visibility of the blood level. Products that are awkward to handle may increase collection time and the risk of accidental injury.

Patient safety considerations include the number of tubes required, total blood volume, potential need for redraws, and suitability for pediatric, geriatric, oncology, and critically ill patients. Smaller-volume tubes can be valuable in settings where cumulative blood loss is a concern, but the laboratory must verify that the available volume is sufficient for the assay and analyzer.

Training is necessary whenever a new tube, additive, draw volume, or order-of-draw requirement is introduced. Training should cover tube identification, fill requirements, mixing, Clotting Time, centrifugation, storage, transport, and rejection criteria. Competency records should be maintained as part of the facility’s personnel and quality systems.

14. Establish a Formal Supplier-Qualification Process

A structured supplier-qualification process helps prevent inconsistent purchasing across departments. The process should involve procurement, laboratory leadership, nursing or phlebotomy management, infection prevention, quality assurance, materials management, and, when appropriate, information technology and finance.

A supplier questionnaire can request information about manufacturing locations, regulatory status, quality certifications, complaint rates, recalls, product changes, lot traceability, lead times, and business continuity. References from comparable U.S. laboratories may also provide useful information about delivery performance and customer service.

Organizations should score suppliers against predetermined criteria rather than choosing informally. A sample evaluation may assign weight to clinical suitability, regulatory documentation, quality history, supply continuity, service, cost, and sustainability. The scoring model should reflect the organization’s risk tolerance and patient population.

Contracts should include clear requirements for product substitutions. A supplier should not replace a specified tube with a different brand, additive concentration, size, or manufacturing location without written approval. Change notification periods are particularly important for laboratories that must complete verification before implementation.

15. Manage Inventory Using Data

Effective inventory management reduces both shortages and expiration waste. Facilities should track average daily and monthly consumption by tube type, seasonal changes, emergency demand, lead time, and safety-stock requirements. Consumption often varies between inpatient units, outpatient draw centers, emergency departments, and specialty clinics.

Useful inventory controls include:

1. Minimum and maximum stock levels for each tube type.
2. Reorder points based on actual lead time and demand variability.
3. Separate storage for quarantined, damaged, recalled, or expired products.
4. Lot and expiration tracking.
5. Routine cycle counts.
6. First-expire, first-out rotation.
7. Periodic review of unused or slow-moving products.

Inventory software or an enterprise resource planning system can help consolidate orders and identify consumption trends. However, technology does not replace physical inspection. Staff should routinely verify that the correct tube is stored in the correct location and that similar-looking products are clearly separated.

16. Monitor Performance After Purchase

Supplier selection should be followed by ongoing performance monitoring. Establishing baseline metrics makes it possible to determine whether a new product is meeting expectations. Important measures include Specimen Rejection rate, hemolysis rate, clotted specimen rate, insufficient-volume rate, leakage incidents, delivery accuracy, back orders, and expired inventory.

Laboratories should investigate trends rather than isolated incidents. A rise in rejected coagulation specimens might reflect tube underfilling, a change in vacuum, collection technique, transportation, or patient population. A rise in hemolysis might involve needle selection, collection site, mixing, pneumatic transport, or tube design.

Supplier review meetings can address recurring problems, corrective actions, and upcoming changes. Serious quality events should be escalated through the organization’s incident-reporting process. Recalls and safety notices should be communicated quickly to all affected collection locations.

17. Questions to Ask Before Signing a Purchase Agreement

Before approving a U.S. blood collection tube supplier, purchasing teams should obtain written answers to the following questions:

1. Is the product legally marketed for its stated intended use in the United States?
2. Which tests and specimen types is the tube designed to support?
3. What additive is present, and what is its concentration?
4. What is the nominal draw volume and acceptable fill range?
5. What are the storage conditions and remaining shelf life at delivery?
6. How are manufacturing lots tested and released?
7. Can the supplier provide lot-level traceability and recall support?
8. What is the supplier’s normal lead time and shortage-allocation policy?
9. How are product changes and manufacturing-site changes communicated?
10. Is the product compatible with existing holders, centrifuges, analyzers, racks, and transport systems?
11. What technical support is available for verification and troubleshooting?
12. What are the policies for damaged shipments, defects, returns, credits, and replacements?

Conclusion

Purchasing blood collection tubes in the United States is a clinical quality decision as well as a procurement decision. The correct product must be compatible with the intended laboratory test, additive requirements, specimen volume, patient population, collection equipment, transport process, and analyzer platform. Regulatory documentation, quality systems, lot traceability, shelf life, storage, and supplier continuity are equally important.

Organizations should assess total cost rather than unit price alone. Reliable tubes can reduce Specimen Rejection, redraws, delays, waste, and staff time. A formal supplier-qualification process, documented verification, inventory controls, and ongoing performance monitoring provide additional protection against quality failures and shortages.

By combining laboratory expertise with disciplined procurement practices, U.S. healthcare facilities can select blood collection tubes that support accurate results, safer phlebotomy, regulatory compliance, and dependable patient care.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos